Middle East Pharmaceutical Industries Company
Middle East Pharmaceutical Industries Company (MEPIC), headquartered in Saudi Arabia, is a prominent player in the pharmaceutical industry, specialising in the development and manufacturing of high-quality generic and branded medications. Established in the early 1990s, MEPIC has achieved significant milestones, including the expansion of its operational footprint across the Middle East and North Africa (MENA) region. MEPIC's core product offerings encompass a diverse range of therapeutic areas, including cardiovascular, anti-infective, and central nervous system medications. What sets MEPIC apart is its commitment to innovation and quality, ensuring that all products meet stringent international standards. With a strong market position, MEPIC has garnered recognition for its contributions to healthcare, making it a trusted name among healthcare professionals and patients alike.
DitchCarbon Score
How does Middle East Pharmaceutical Industries Company's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Chemicals industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Middle East Pharmaceutical Industries Company's score of 10 is lower than 56% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Middle East Pharmaceutical Industries Company's reported carbon emissions
Middle East Pharmaceutical Industries Company, headquartered in Saudi Arabia, currently does not have available data on carbon emissions, as no specific emissions figures have been provided. Additionally, there are no documented reduction targets or climate pledges outlined by the company. In the context of the pharmaceutical industry, companies are increasingly recognising the importance of addressing climate change and reducing their carbon footprints. While specific commitments from Middle East Pharmaceutical Industries Company are not available, the industry as a whole is moving towards more sustainable practices and setting ambitious targets to mitigate climate impacts. As the company progresses, it may consider establishing measurable goals aligned with global climate initiatives to enhance its environmental responsibility and transparency.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Middle East Pharmaceutical Industries Company is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
